NSE: CONCORDBIO
CONCORD BIOTECH LIMITED
Price history
+12.09% over 3M
Performance
52-week range
Position in day range
CONCORDBIO stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Uptrend
50-DMA ₹1,406.7
RSI (14)
45
Neutral momentum
Volatility (ATR)
3.32%
Moderate
Close streak
1d up
Volume vs 20d avg
2.11x
Unusual activity
From 52W high
-11.64%
Up from 52W low
+52.55%
Green days (20)
7/20
Monthly seasonality
Average monthly move for CONCORDBIO across the available price history.
Key statistics
Open
1,439.6
Day high
1,529
Day low
1,426.9
Prev close
1,505.7
Volume
3.73 L
Avg vol (20d)
1.77 L
52W high
1,704
52W low
987
CONCORDBIO quarterly results
All CONCORDBIO results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹257 cr
+26.2% YoY
Net profit
₹57.7 cr
+31.0% YoY
Operating profit
₹64.28 cr
+47.4% YoY
EPS
₹8.46
+101.0% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹257 cr | ₹64.28 cr | ₹57.7 cr | 25.0% | 22.4% | ₹8.46 | +31.0% | -35.0% |
| Q4 FY262026-03-31 | ₹326 cr | ₹98.99 cr | ₹88.79 cr | 30.4% | 27.2% | ₹8.46 | — | +39.5% |
| Q3 FY262025-12-31 | ₹278 cr | ₹80.23 cr | ₹63.64 cr | 28.9% | 22.9% | ₹6.08 | — | +0.9% |
| Q2 FY262025-09-30 | ₹247 cr | ₹70.1 cr | ₹63.06 cr | 28.4% | 25.5% | ₹6.03 | — | +43.1% |
| Q1 FY262025-06-30 | ₹204 cr | ₹43.62 cr | ₹44.06 cr | 21.4% | 21.6% | ₹4.21 | — | — |
| TTM (last 4 quarters) | ₹1,108 cr | ₹314 cr | ₹273 cr | 28.3% | 24.6% | ₹29.03 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
No stories tagged with CONCORDBIO yet — see the latest from the markets desk below.
Latest market news
Jubilant Pharmova Share Price Trades Flat at ₹1,025.20 Today — Volumes, 52-Week Range and What to Watch Next
Jubilant Pharmova (JUBLPHARMA) trades at ₹1,025.20, -0.45 (-0.04%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Coforge Share Price Opens Gap-Down at ₹1,807.30: What Is Driving COFORGE Today, and the Levels That Matter
Coforge (COFORGE) trades at ₹1,846.50, +13.40 (+0.73%) as the in-focus story plays out. Live board, day range, twelve-month context and the follow-up that decides the next session.
Aavas Financiers Share Price Edges Lower to ₹1,271.50 Today — Volumes, 52-Week Range and What to Watch Next
Aavas Financiers (AAVAS) trades at ₹1,271.50, -14.60 (-1.15%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
HDFC AMC Edges Lower to ₹2,403.90 — Should Investors Read This as a Trend or a One-Day Move?
HDFC AMC (HDFCAMC) trades at ₹2,403.90, -29.90 (-1.24%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Price and history data from NSE via Upstox. For information only, not investment advice.